Skip to main content
Erschienen in: Clinical and Experimental Nephrology 6/2017

03.03.2017 | Original article

Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008–2012

verfasst von: Kunitoshi Iseki, Koichi Asahi, Kunihiro Yamagata, Shouichi Fujimoto, Kazuhiko Tsuruya, Ichiei Narita, Tsuneo Konta, Masato Kasahara, Yugo Shibagaki, Hisako Yoshida, Toshiki Moriyama, Masahide Kondo, Chiho Iseki, Tsuyoshi Watanabe, for the “Design of the comprehensive health care system for chronic kidney disease (CKD) based on the individual risk assessment by Specific Health Check”

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

In Japan, the Specific Health Check and Guidance (Tokutei-Kenshin) has started in 2008. However, the relationship between the baseline characteristics and mortality has not been examined.

Methods

Subjects were those who participated at the 2008 Tokutei-Kenshin in six districts with baseline data of serum creatinine. Using National database of death certificate from 2008 to 2012, we identified those who might have died and confirmed further with the collaborations of the regional National Health Insurance agency and public health nurses. The data was released to the research team supported by the Ministry of Health, Labor, and Welfare of Japan, and is governed by strict regulation and is completely encrypted with the individual’s name and residence. Causes of death were classified by ICD-10.

Results

Among the total of 295,297 subjects, we identified 3764 fatal cases by end of 2012. The median BMI was 23.8 kg/m2 in men and 22.5 kg/m2 in women, respectively. Proteinuria, dipstick 1+ and over, was positive in 5.3%. The median eGFR was 73.8 ml/min/1.73 m2 among those with data available in 81% of the total cohort (N = 239,274). The leading cause of death was neoplasm in both genders. It was 51.6% of the total, 50.4% in men and 53.7% in women. The second cause of death was circulatory; 20.4% of the total, 21.1% in men and 19.2% in women.

Conclusion

Half of the causes of death was related to neoplasm among the cohort of the Tokutei-Kenshin. Effects of baseline demographics such as lifestyle and CKD remained to be studied.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Perkovic V, Agarwal R, Fioretto P, Hemmelgarn BR, Levin A, Thomas MC, et al. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int. 2016;90:1175–83.CrossRefPubMed Perkovic V, Agarwal R, Fioretto P, Hemmelgarn BR, Levin A, Thomas MC, et al. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int. 2016;90:1175–83.CrossRefPubMed
3.
Zurück zum Zitat Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63(3):793–808.CrossRefPubMed Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63(3):793–808.CrossRefPubMed
4.
Zurück zum Zitat Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality: a meta-analysis from the CKD prognosis consortium. JAMA. 2014;311:2518–31.CrossRefPubMedPubMedCentral Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality: a meta-analysis from the CKD prognosis consortium. JAMA. 2014;311:2518–31.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Iseki K, Asahi K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, et al. Risk factor profiles based on eGFR and dipstick proteinuria: analysis of the participants of the Specific Health Check and Guidance System in Japan 2008. Clin Exp Nephrol. 2012;16:244–9.CrossRefPubMed Iseki K, Asahi K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, et al. Risk factor profiles based on eGFR and dipstick proteinuria: analysis of the participants of the Specific Health Check and Guidance System in Japan 2008. Clin Exp Nephrol. 2012;16:244–9.CrossRefPubMed
6.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.CrossRefPubMed
7.
Zurück zum Zitat Definition and Criteria of Diagnosis of Metabolic Syndrome. Committee for the Diagnosis of Metabolic Syndrome. (Japanese). J Jpn Soc Int Med. 2007;94:794–809. Definition and Criteria of Diagnosis of Metabolic Syndrome. Committee for the Diagnosis of Metabolic Syndrome. (Japanese). J Jpn Soc Int Med. 2007;94:794–809.
8.
Zurück zum Zitat Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11:51–5.CrossRefPubMed Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11:51–5.CrossRefPubMed
9.
Zurück zum Zitat Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi K, Moriyama T, et al. Budget impact analysis of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2014;18(6):885–91.CrossRefPubMedPubMedCentral Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi K, Moriyama T, et al. Budget impact analysis of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2014;18(6):885–91.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80(1):17–28.CrossRefPubMed Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80(1):17–28.CrossRefPubMed
11.
Zurück zum Zitat Konta T, Ikeda A, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, et al. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort. Am J Hypertens. 2012;25:342–7.CrossRefPubMed Konta T, Ikeda A, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, et al. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort. Am J Hypertens. 2012;25:342–7.CrossRefPubMed
12.
Zurück zum Zitat Yano Y, Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, et al. Association of high pulse pressure with proteinuria in subjects with diabetes, pre-diabetes or normal glucose tolerance in a large Japanese general population sample. Diabetes Care. 2012;35:1310–5.CrossRefPubMedPubMedCentral Yano Y, Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, et al. Association of high pulse pressure with proteinuria in subjects with diabetes, pre-diabetes or normal glucose tolerance in a large Japanese general population sample. Diabetes Care. 2012;35:1310–5.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Yano Y, Fujimoto S, Kramer H, Sato Y, Konta T, Iseki K, et al. Long-term blood pressure variability, new-onset diabetes, and new-onset chronic kidney disease in the Japanese general population. Hypertension. 2015;66:30–6.CrossRefPubMed Yano Y, Fujimoto S, Kramer H, Sato Y, Konta T, Iseki K, et al. Long-term blood pressure variability, new-onset diabetes, and new-onset chronic kidney disease in the Japanese general population. Hypertension. 2015;66:30–6.CrossRefPubMed
14.
Zurück zum Zitat Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, et al. Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of chronic kidney disease: a longitudinal study in a large Japanese population. Am J Kidney Dis. 2015;66:972–83.CrossRefPubMed Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, et al. Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of chronic kidney disease: a longitudinal study in a large Japanese population. Am J Kidney Dis. 2015;66:972–83.CrossRefPubMed
15.
Zurück zum Zitat Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382:260–72.CrossRef Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382:260–72.CrossRef
16.
Zurück zum Zitat Li PK, Chow KM, Matsuo S, Yang CW, Jha V, Becker G, et al. Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology. 2011;16:633–41.PubMed Li PK, Chow KM, Matsuo S, Yang CW, Jha V, Becker G, et al. Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology. 2011;16:633–41.PubMed
17.
Zurück zum Zitat Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905–6.CrossRefPubMed Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905–6.CrossRefPubMed
18.
Zurück zum Zitat Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–8.CrossRefPubMed Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–8.CrossRefPubMed
19.
Zurück zum Zitat Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–6.CrossRefPubMed Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–6.CrossRefPubMed
20.
Zurück zum Zitat Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark D, et al. Past decline versus current eGFR and subsequent ESRD risk. J Am Soc Nephrol. 2015;27(8):2447–55.CrossRefPubMedPubMedCentral Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark D, et al. Past decline versus current eGFR and subsequent ESRD risk. J Am Soc Nephrol. 2015;27(8):2447–55.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Wakasugi M, Kazama JJ, Narita I, Iseki K, Fujimoto S, Moriyama T, et al. Association between overall lifestyle changes and the incidence of proteinuria: a population-based, cohort study. Intern. Med. 2016 (in press). Wakasugi M, Kazama JJ, Narita I, Iseki K, Fujimoto S, Moriyama T, et al. Association between overall lifestyle changes and the incidence of proteinuria: a population-based, cohort study. Intern. Med. 2016 (in press).
22.
Zurück zum Zitat Hallan SI, Øvrehus MA, Romundstad S, Rifkin D, Langhammer A, Stevens PE, et al. Long-term trends with prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway. Kidney Int. 2016;90:665–73.CrossRefPubMed Hallan SI, Øvrehus MA, Romundstad S, Rifkin D, Langhammer A, Stevens PE, et al. Long-term trends with prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway. Kidney Int. 2016;90:665–73.CrossRefPubMed
Metadaten
Titel
Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008–2012
verfasst von
Kunitoshi Iseki
Koichi Asahi
Kunihiro Yamagata
Shouichi Fujimoto
Kazuhiko Tsuruya
Ichiei Narita
Tsuneo Konta
Masato Kasahara
Yugo Shibagaki
Hisako Yoshida
Toshiki Moriyama
Masahide Kondo
Chiho Iseki
Tsuyoshi Watanabe
for the “Design of the comprehensive health care system for chronic kidney disease (CKD) based on the individual risk assessment by Specific Health Check”
Publikationsdatum
03.03.2017
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 6/2017
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-017-1392-y

Weitere Artikel der Ausgabe 6/2017

Clinical and Experimental Nephrology 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.